- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02155036
Effect of Exercise on Renal Function in Predialysis
The Effect of Exercise on Renal Function and Cardiovascular Disease in Pre-dialysis (Chronic Kidney Disease Stage 3-4) Patients With Chronic Kidney Disease; a Randomised Controlled Trial Pilot Study.
The proposed research aims to examine whether regular aerobic exercise can preserve renal function, improve aerobic capacity, physical and psychosocial function, strength, cardiovascular function, general well-being and quality of life. Ultimately, the research aims to prove that exercise is a more cost-effective and a more efficient use or healthcare resources used in the treatment of patients with CKD. Exercise is a relatively cheap treatment option which is readily available and accessible for this patient population. establish if, compared with usual care, an exercise programme for pre-dialysis CKD patients;
- Preserves renal function.
- Improves aerobic capacity, physical and psychosocial function, strength, cardiovascular function, general well-being and quality of life.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SE5 9RS
- King's College Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- - Stages 3-4 chronic kidney disease (CKD) patients (glomerular filtration rate (GFR) 20-60 mL/min)
- Male or female
- Aged >18 years
- Written informed consent
Exclusion Criteria:
Pregnancy
- Requiring support for ambulation less than 20m
- Vasculitis,
- Proliferative diabetic retinopathy,
- Severe osteodystrophy,
- Uncontrolled diabetes,
- Psychiatric illness, including anxiety, mood and untreated eating disorders
- Infection or course of antibiotics within the last month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual care
|
|
|
Active Comparator: Exercise
exercise intervention
|
The intervention will include 2 sessions of gym-based exercise per week, both of which will be supervised for 3 months, supervision will then decrease to once-weekly until 6 months, and then be through phone support for the remaining 6 months.
Warm up and cool down of minimum of five minutes on stationary exercise cycle, rate of perceived exertion (RPE) ~11, followed by gentle stretching.
Progressive resistance training (PRT) will use eight PRT machines training large muscle groups (e.g.
bench press, latissimus pulldown, bicep curl, triceps pull down, leg press, knee extension, hamstring curl, calf raises).
Intensity will be 80% of one repetition maximum (1RM), building up to 3 sets of 8 repetitions.
1RM will be re-assessed monthly, and program adjusted accordingly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
kidney function
Time Frame: up to 12 months
|
estimated glomerular filtration rate (egfr) creatinine
|
up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardio-respiratory fitness testing (VO2peak)
Time Frame: Baseline, 6 and 12 months
|
cycle ergometer
|
Baseline, 6 and 12 months
|
|
Pulse Wave Velocity (arterial stiffness)
Time Frame: Baseline, 6 and 12 months
|
Vicorder equipment, carotid-femoral region.
|
Baseline, 6 and 12 months
|
|
Body mass index (BMI)
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
weight
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
Waist circumference
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
Duke's activity status index
Time Frame: Baseline, 6 and 12 months
|
questionnaire
|
Baseline, 6 and 12 months
|
|
Short Form 36 questionnaire
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
Total cholesterol
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
High sensitivity c-reactive protein (Hs CRP)
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
Blood pressure
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
Resting heart rate (HR)
Time Frame: Baseline, 6 and 12 months
|
Baseline, 6 and 12 months
|
|
|
Triglycerides
Time Frame: baseline, 6 and 12 months
|
baseline, 6 and 12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: sharlene greenwood, Bsc, King's College Hospital NHS Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KCH11-123
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.